Use your antibodies-online credentials, if available.
No Products on your Comparison List.
Your basket is empty.
Find out more
CNBP encodes a nucleic-acid binding protein with seven zinc-finger domains. Additionally we are shipping CNBP Proteins (12) and CNBP Kits (1) and many more products for this protein.
Showing 10 out of 90 products:
Human Polyclonal CNBP Primary Antibody for WB - ABIN1881216
Panayiotopoulos, Scarpalezos: Dystrophia myotonica. Peripheral nerve involvement and pathogenetic implications. in Journal of the neurological sciences 1976
Show all 4 references for ABIN1881216
Human Polyclonal CNBP Primary Antibody for IHC (p), WB - ABIN650981
Gerbasi, Link: The myotonic dystrophy type 2 protein ZNF9 is part of an ITAF complex that promotes cap-independent translation. in Molecular & cellular proteomics : MCP 2007
Dog (Canine) Polyclonal CNBP Primary Antibody for WB - ABIN374675
Day, Ricker, Jacobsen, Rasmussen, Dick, Kress, Schneider, Koch, Beilman, Harrison, Dalton, Ranum: Myotonic dystrophy type 2: molecular, diagnostic and clinical spectrum. in Neurology 2003
High CNBP expression is associated with Medulloblastoma.
CNBP overexpression caused increase of cell death and suppression of cell metastasis through its induction of G-quadruplex formation in the promoter of hnRNP K (show HNRNPK Antibodies) resulting in hnRNP K (show HNRNPK Antibodies) down-regulation
Arginine methylation of CNBP in the RG motif does not change the subcellular localization but regulates its RNA binding activity.
CNBP are novel antigens for SLE patients and the recognition of CNBP might be differentiated dependent on the level of arginine methylation.
suggested a new possibility of CNBP as a potential anti-cancer target based on CNBP's biological function in c-myc (show MYC Antibodies) transcription
CNBP associates with the poly(A) binding protein and accumulates in stress granules.
The co-segregation of Myotonic dystrophy type 2 with a recessive CLCN1 (show CLCN1 Antibodies) mutation provided the explanation for the unusual clinical findings for juvenile onset of myotonia in a 14-year-old female with Myotonic dystrophy type 2 and her affected mother
Myotonic dystrophy 2(autosomal dominant, multisystem disorder caused by a CCTG (show CCT3 Antibodies) tetranucleotide repeat expansion located in intron 1 of the zinc finger protein 9 gene (ZNF9 gene) on chromosome 3q 21.3.) described in Israeli Jewish European ancestry.
CCTG (show CCT3 Antibodies) repeat expansions in the CNBP gene are responsible for myotonic dystrophy type 2.
Study concludes that DM2 patients from the Netherlands, including a North-African family, harbor a common haplotype surrounding the ZNF9 gene.
CNBP up-regulates tbx2b and smarca5 (show SMARCA5 Antibodies), and down-regulates wnt5b (show WNT5B Antibodies) gene expression.
expression of APP (show APP Antibodies)(Swe) in murine tissue induces a decrease in CNBP expression.
CNBP targets Myc (show MYC Antibodies) in rostral head formation, is essential for forebrain induction and specification.
This gene encodes a nucleic-acid binding protein with seven zinc-finger domains. The protein has a preference for binding single stranded DNA and RNA. The protein functions in cap-independent translation of ornithine decarboxylase mRNA, and may also function in sterol-mediated transcriptional regulation. A CCTG expansion in the first intron of this gene results in myotonic dystrophy type 2. Multiple transcript variants encoding different isoforms have been found for this gene.
cellular nucleic acid-binding protein
, zinc finger protein 9
, cellular nucleic acid binding protein
, erythroid differentiation-related
, sterol regulatory element-binding protein
, zinc finger protein 273
, zinc finger protein 9 (a cellular retroviral nucleic acid binding protein)
, cellular nucleic acid binding protein 1
, cellular nucleic acid binding protein a
, DNA binding protein